NDC product
Medi-First Plus Triple Antibiotic
NDC 47682-938 · Unifirst First Aid Corporation
Key facts
| Product NDC | 47682-938 |
|---|---|
| Proprietary name | Medi-First Plus Triple Antibiotic |
| Nonproprietary name | Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate |
| Substances | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BACITRACIN ZINC |
| Dosage form | OINTMENT |
| Route | TOPICAL |
| Labeler | Unifirst First Aid Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M004 |
| Pharmacologic classes | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
| Marketing start | Jun 1, 2021 |
| Marketing end | Apr 30, 2028 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory